These seller's timelines are so short they are happy to take a loss, in order to gamble on EM signatures and SPECTACULAR intervals of massive pyrrhotite, lol.
Assume Euroz is correct that Goulamina is worth 60M as is.That means the 1.49Moz resource and currently producing 4.5Mt plant, plus 300-500Koz expansion on the way, is valued at a mere 40M, if you believe in the "efficient market theory".
What other company that will soon be producing 140Koz @ 80% ownership for 10+ years is valued at 40M? Morila will be making 40M USD (54M AUD) NPAT per annum for FFX in the near future, with comparatively zero financial risk - more than this apparent valuation. (Assuming 600 USD margin, 30% net tax, 90% recovery).
It's highly likely that Goulamina will move into construction in the next two years as well. As things currently stand, Morila gold income lowers finance risk for Goulamina. So its 60M valuation should be adjusted to reflect that as well, vs lithium peers.
Safe to say the market is currently wrong on this one. The question is when will it be right?
- Forums
- ASX - By Stock
- FFX
- Who’s buying and selling
Who’s buying and selling, page-178
-
- There are more pages in this discussion • 1,958 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add FFX (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online